Transluminal Coronary Angioplasty—1981
- 1 April 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 142 (4) , 679-680
- https://doi.org/10.1001/archinte.1982.00340170035004
Abstract
The original clinical investigators of percutaneous transluminal coronary angioplasty (PTCA) are now into the fourth year of their experience.1-4Since the first PTCA performed by Grüntzig and co-workers1in Zurich, Switzerland, in 1977, more than 3,500 of these procedures have been attempted in Europe and in the Western hemisphere. As with most new therapies, the question properly arises: When does such a technique safely move from the investigative stage to responsible clinical practice? Grüntzig, Myler, and Stertzer are now able to show an approximate 85% sustained patency rate in a series of single-vessel cases of PTCA followed up for 36 months.5Moreover, many patients are pain free, have normal results from a thallous chloride Tl 201 scan during exercise, and have normal angiograms 40 months after PTCA. It also seems that the majority of single-vessel recurrences after PTCA are readily and safely disposed to successful second dilation,This publication has 1 reference indexed in Scilit:
- TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSISThe Lancet, 1978